Biosino Bio-Technology and Science Inc. has announced that it has entered into a strategic cooperation agreement with Guangdong Xiaoshou Medical Technology Co., Ltd. The partnership aims to promote the extension of quality medical resources and enhance service capabilities in primary healthcare institutions. Under the agreement, Biosino intends to make a strategic investment in Xiaoshou Medical, fostering a long-term partnership and exploring innovative development models in the primary healthcare market. The collaboration will leverage Biosino’s strengths in in-vitro diagnostics and Xiaoshou Medical’s extensive healthcare channel network to distribute diagnostic products and solutions to primary healthcare providers.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biosino Bio-Technology and Science Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260211-12022048), on February 11, 2026, and is solely responsible for the information contained therein.